Ms. Seltzer serves as an Associate of Aisling Capital. Previously, Ms. Seltzer was an Associate Director at Schering-Plough, where she held roles in global licensing, sales, and as the US SP brand lead for Zetia. While in business development, Ms. Seltzer was involved in the creation, structuring and negotiation of several deals with an aggregate value in the billions, ranging from licensing deals to broad development and commercialization alliances. Prior to Schering-Plough, Ms. Seltzer was the Director of Business Development for Akceli, a biotechnology company developing cell-based microarrays. Ms. Seltzer began her career as a Business Analyst for McKinsey & Company.

Ms. Seltzer received her M.B.A. from The Wharton School at the University of Pennsylvania, where she was a Palmer Scholar. She received her M.S. and B.S. from Yale University, awarded cum laude in Molecular Biophysics and Biochemistry.

Dennis Purcell
Steven A. Elms
Andrew Schiff
Dov A. Goldstein
Anthony Y. Sun
Brett I.W. Zbar
Josh Bilenker
Aftab R. Kherani
Stacey D. Seltzer
Christine Lee Ha
Justin Sun
Jacob Van Naarden
Lloyd E. Appel
Andrew P. Nicholson
Robert J. Wenzel
Diana Robinson
Jan Hoerrner